✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Lobeline is an investigational drug.
There have been 5 clinical trials for Lobeline. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2008.
The most common disease conditions in clinical trials are Neoplasm Metastasis, Attention Deficit Disorder with Hyperactivity, and Amphetamine-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and Yaupon Therapeutics.
Recent Clinical Trials for Lobeline
|Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor||Alphacait, LLC||Phase 2|
|Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients||National Institute of Mental Health (NIMH)||Phase 2|